A Study to Test Trametinib and dabrafenib in Children and Adolescents Subjects with Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-003596-35

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine the safe and tolerable trametinib dose(s) for chronic continuous daily dosing in pediatric subjects (infants, children, and adolescents) that achieves similar exposures (trough concentration [Ct]) to the recommended adult dose.


Critère d'inclusion

  • Children and Adolescents with Cancers Harboring V600 mutations

Liens